- Home
- CXDO vs ACHV Comparison
CXDO vs ACHV Comparison
Compare CXDO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- ACHV
- Stock Information
- Founded
- CXDO 1995
- ACHV N/A
- Country
- CXDO United States
- ACHV Canada
- Employees
- CXDO N/A
- ACHV N/A
- Industry
- CXDO Telecommunications Equipment
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CXDO Telecommunications
- ACHV Health Care
- Exchange
- CXDO Nasdaq
- ACHV Nasdaq
- Market Cap
- CXDO 155.2M
- ACHV 159.0M
- IPO Year
- CXDO 1998
- ACHV N/A
- Fundamental
- Price
- CXDO $4.96
- ACHV $4.25
- Analyst Decision
- CXDO Strong Buy
- ACHV Strong Buy
- Analyst Count
- CXDO 2
- ACHV 5
- Target Price
- CXDO $6.50
- ACHV $14.80
- AVG Volume (30 Days)
- CXDO 166.1K
- ACHV 112.1K
- Earning Date
- CXDO 11-06-2024
- ACHV 11-07-2024
- Dividend Yield
- CXDO N/A
- ACHV N/A
- EPS Growth
- CXDO N/A
- ACHV N/A
- EPS
- CXDO 0.05
- ACHV N/A
- Revenue
- CXDO $58,762,000.00
- ACHV N/A
- Revenue This Year
- CXDO $15.54
- ACHV N/A
- Revenue Next Year
- CXDO $10.50
- ACHV N/A
- P/E Ratio
- CXDO $106.68
- ACHV N/A
- Revenue Growth
- CXDO 16.41
- ACHV N/A
- 52 Week Low
- CXDO $2.35
- ACHV $3.03
- 52 Week High
- CXDO $7.59
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- CXDO 40.87
- ACHV 35.58
- Support Level
- CXDO $5.00
- ACHV $4.32
- Resistance Level
- CXDO $6.10
- ACHV $4.75
- Average True Range (ATR)
- CXDO 0.33
- ACHV 0.23
- MACD
- CXDO -0.11
- ACHV -0.06
- Stochastic Oscillator
- CXDO 13.64
- ACHV 9.40
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.